October 07, 2025

FDA Announces New Development in Lung Care

The FDA has approved the first treatment in more than a decade for idiopathic pulmonary fibrosis.

Conexiant

October 06, 2025

Evidence-Based Medicine Requires Urgent Reform, Physician Says

Systemic biases and industry influence have undermined the movement's foundational principles, potentially compromising patient care across multiple specialties.

Conexiant

October 01, 2025

Remibrutinib Gains FDA Nod for Urticaria

First oral BTK inhibitor approved for antihistamine-resistant chronic spontaneous urticaria, targeting mast cell–driven immune dysregulation

Conexiant

September 30, 2025

Med Diet: New Angle on Gum Disease?

Study links red meat consumption and poor diet quality to severe gum disease in 195 UK patients.

Conexiant

September 29, 2025

FDA Expands Options for Pediatric Psoriasis, PsA

The FDA has approved the first IL-23 inhibitor for pediatric patients with plaque psoriasis and psoriatic arthritis.

Conexiant

September 26, 2025

Old Medicine, New Hope for Speech?

Leucovorin, a folic acid–derived drug, is under study for speech benefits in children with autism.

KFF Health News

September 24, 2025

Who Holds the Power on Vaccines Now?

Vaccine recommendations face increasing state-level variation following ACIP and CDC changes.

KFF Health News

September 24, 2025

Can Psychedelics Influence the Immune System?

Researchers from the University of Birmingham examine the effects of psychedelic drugs on the immune system – but are they trippin’?

The Medicine Maker

September 23, 2025

ACOG Counters Federal Acetaminophen Concerns

Steven J. Fleischman, MD, MBA, FACOG, president of the American College of Obstetricians and Gynecologists released remarks on analgesic safety for patients who are pregnant.

Conexiant